Tag: cancer
-
Liquid Biopsy Company Gains $360M for Cancer Sequencing
A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer.
-
Personalized Drug Delivery System Demonstrated
Biomedical engineers developed and demonstrated in lab animals a closed-loop system that monitors and controls delivery of drugs to meet an individual’s personalized needs.
-
Sound Waves, Nanotech Delivery Boost Cancer Drug
Focused sound waves aimed at nanoscale bubbles filled with a cancer drug, were shown in lab mice to improve delivery of the drug to a particularly hard-to-treat cancer.
-
$2 Billion Biotech Licensing Deal Cancelled
A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday.
-
FDA Warns Cancer Fraud Product Providers
The Food and Drug Administration sent warning letters to 14 companies in the U.S. that the agency says are selling products fraudulently claiming to prevent, diagnose, treat, or cure cancer.
-
Nanoparticle Vaccine Stops Tumor Growth
Researchers in Texas designed a cancer vaccine with nanoscale particles that in lab mice stimulates the immune system and stops the growth of several types of tumors.
-
Nanoparticles Boost T-Cells to Fight Leukemia
A cancer research lab designed a process to treat leukemia by reprogramming cells in the immune system with genes on nanoscale biodegradable particles.
-
Crispr-Based Diagnostics System Designed
A bioengineering team from Harvard University and Massachusetts Institute of Technology designed simple, inexpensive diagnostics tools to detect infectious diseases, based on Crispr, an emerging genome-editing technology.
-
Cancer Gene Therapy Company Raises $85M in IPO
A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering.
-
Prodrugs Designed to Better Target Cancer Therapies
A delivery mechanism is being developed to package cancer drugs in a nanoscale precursor state that reacts only in tumor regions, to protect against adverse effects.